First-time disclosure of IPN60090, a potent and selective GLS1 inhibitor with excellent physicochemical properties, targeting cancers with specific metabolic vulnerabilities Dr. Michael Soth , Kang Le , Gang Liu , Jeffrey J. Kovacs , Jason P. Burke , Jennifer Bardenhagen , Christopher Bristow , Barbara Czako , Chris Carroll , Maria E. Di Francesco , Matthew M . Hamilton , Mary Geck Do , Angela Harris , Virginia Giuliani , Sha Huang , Yongying Jiang , Troy Johnson , Zhijun Kang , Zhen Liu , Timothy McAfoos , Meredith Miller , Pietro Morlacchi , Wylie S. Palmer , Jihai Pang , Norma Rogers , Hannah Shepard , Nakia D. Spencer , Jay Theroff , Quanyun Xu , Anne Yau , Giulio Draetta , Carlo Toniatti , Natalya Nazarenko , Timothy P. Heffernan , Philip Jones semanticscholar（2020）
AI 理解论文
溯源树
样例
